172 related articles for article (PubMed ID: 16311053)
1. Regulation of insulin-like growth factor binding protein-5, four and a half lim-2, and a disintegrin and metalloprotease-9 expression in osteoblasts.
Govoni KE; Amaar YG; Kramer A; Winter E; Baylink DJ; Mohan S
Growth Horm IGF Res; 2006 Feb; 16(1):49-56. PubMed ID: 16311053
[TBL] [Abstract][Full Text] [Related]
2. Osteoblast-specific expression of insulin-like growth factor-1 in bone of transgenic mice induces insulin-like growth factor binding protein-5.
Rutter MM; Markoff E; Clayton L; Akeno N; Zhao G; Clemens TL; Chernausek SD
Bone; 2005 Feb; 36(2):224-31. PubMed ID: 15780948
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-binding protein 5 (IGFBP-5) interacts with a four and a half LIM protein 2 (FHL2).
Amaar YG; Thompson GR; Linkhart TA; Chen ST; Baylink DJ; Mohan S
J Biol Chem; 2002 Apr; 277(14):12053-60. PubMed ID: 11821401
[TBL] [Abstract][Full Text] [Related]
4. Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation.
Yeh LC; Adamo ML; Olson MS; Lee JC
Endocrinology; 1997 Oct; 138(10):4181-90. PubMed ID: 9322928
[TBL] [Abstract][Full Text] [Related]
5. Regulation of insulin-like growth factors I and II and their binding proteins in human bone marrow stromal cells by dexamethasone.
Cheng SL; Zhang SF; Mohan S; Lecanda F; Fausto A; Hunt AH; Canalis E; Avioli LV
J Cell Biochem; 1998 Dec; 71(3):449-58. PubMed ID: 9831081
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor binding Protein-3 suppresses osteoblast differentiation via bone morphogenetic protein-2.
Eguchi K; Akiba Y; Akiba N; Nagasawa M; Cooper LF; Uoshima K
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):465-470. PubMed ID: 30454898
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor-binding protein-5 inhibits osteoblast differentiation and skeletal growth by blocking insulin-like growth factor actions.
Mukherjee A; Rotwein P
Mol Endocrinol; 2008 May; 22(5):1238-50. PubMed ID: 18292241
[TBL] [Abstract][Full Text] [Related]
8. ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts.
Mohan S; Thompson GR; Amaar YG; Hathaway G; Tschesche H; Baylink DJ
Biochemistry; 2002 Dec; 41(51):15394-403. PubMed ID: 12484779
[TBL] [Abstract][Full Text] [Related]
9. ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3.
Loechel F; Fox JW; Murphy G; Albrechtsen R; Wewer UM
Biochem Biophys Res Commun; 2000 Nov; 278(3):511-5. PubMed ID: 11095942
[TBL] [Abstract][Full Text] [Related]
10. ADAM 12, a disintegrin metalloprotease, interacts with insulin-like growth factor-binding protein-3.
Shi Z; Xu W; Loechel F; Wewer UM; Murphy LJ
J Biol Chem; 2000 Jun; 275(24):18574-80. PubMed ID: 10849447
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures.
Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B
J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor (IGF)-I, -II, IGF binding proteins (IGFBP)-3, -4, and -5 levels in the conditioned media of normal human bone cells are skeletal site-dependent.
Malpe R; Baylink DJ; Linkhart TA; Wergedal JE; Mohan S
J Bone Miner Res; 1997 Mar; 12(3):423-30. PubMed ID: 9076585
[TBL] [Abstract][Full Text] [Related]
13. The insulin-like growth factor-binding protein-4 (IGFBP-4)-IGFBP-4 protease system in normal human osteoblast-like cells: regulation by transforming growth factor-beta.
Durham SK; Riggs BL; Conover CA
J Clin Endocrinol Metab; 1994 Dec; 79(6):1752-8. PubMed ID: 7527411
[TBL] [Abstract][Full Text] [Related]
14. Osteogenic protein-1 regulates insulin-like growth factor-I (IGF-I), IGF-II, and IGF-binding protein-5 (IGFBP-5) gene expression in fetal rat calvaria cells by different mechanisms.
Yeh LC; Adamo ML; Duan C; Lee JC
J Cell Physiol; 1998 Apr; 175(1):78-88. PubMed ID: 9491783
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic protein-2 inhibits the synthesis of insulin-like growth factor-binding protein-5 in bone cell cultures.
Gabbitas B; Canalis E
Endocrinology; 1995 Jun; 136(6):2397-403. PubMed ID: 7538461
[TBL] [Abstract][Full Text] [Related]
16. Osteoblast differentiation of NIH3T3 fibroblasts is associated with changes in the IGF-I/IGFBP expression pattern.
Abdallah BM
Cell Mol Biol Lett; 2006; 11(4):461-74. PubMed ID: 17001448
[TBL] [Abstract][Full Text] [Related]
17. Disruption of four-and-a-half LIM 2 decreases bone mineral content and bone mineral density in femur and tibia bones of female mice.
Govoni KE; Baylink DJ; Chen J; Mohan S
Calcif Tissue Int; 2006 Aug; 79(2):112-7. PubMed ID: 16927043
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic protein regulation of forkhead/winged helix transcription factor Foxc2 (Mfh1) in a murine mesodermal cell line C1 and in skeletal precursor cells.
Nifuji A; Miura N; Kato N; Kellermann O; Noda M
J Bone Miner Res; 2001 Oct; 16(10):1765-71. PubMed ID: 11585339
[TBL] [Abstract][Full Text] [Related]
19. Response of bipotential human marrow stromal cells to insulin-like growth factors: effect on binding protein production, proliferation, and commitment to osteoblasts and adipocytes.
Thomas T; Gori F; Spelsberg TC; Khosla S; Riggs BL; Conover CA
Endocrinology; 1999 Nov; 140(11):5036-44. PubMed ID: 10537129
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta regulation of the insulin-like growth factor binding protein-4 protease system in cultured human osteoblasts.
Ortiz CO; Chen BK; Bale LK; Overgaard MT; Oxvig C; Conover CA
J Bone Miner Res; 2003 Jun; 18(6):1066-72. PubMed ID: 12817760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
